| Literature DB >> 374194 |
W R Burnham, J E Lennard-Jones, P Hecketsweiler, R Colin, Y Geffroy.
Abstract
In a randomised double-blind trial over one year oral BCG has been compared with a control preparation in the treatment of chronic Crohn's disease. Overall assessment scores deteriorated in nine of 22 patients taking BCG, and 11 of 26 in the control group (P = 0.25); this deterioration was great enough to be regarded as a clinical relapse in three patients taking BCG and in seven taking the control preparation (P greater than 0.1). No significant benefit from oral BCG treatment has been demonstrated.Entities:
Mesh:
Substances:
Year: 1979 PMID: 374194 PMCID: PMC1412307 DOI: 10.1136/gut.20.3.229
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059